Sanofi trial failure halts work on breast cancer treatment amcenestrant
Reuters· 2 hours agoThe move weighed on shares and mounted pressure on Sanofi to bolster its pipeline of drug candidates...
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 9 hours agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...
Sanofi (SNY) Ends Development of Breast Cancer Drug, Stock Down
Zacks via Yahoo Finance· 3 hours agoThe drug is currently approved for eczema, asthma, chronic rhinosinusitis with nasal polyposis and...
Eczema Clinical Trial Pipeline Insights | DelveInsight
Benzinga· 6 days agoNew York, USA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Eczema Clinical Trial Pipeline Insights | DelveInsight The prevalence of eczema is rising since the past few years, which prompts the growing demand for the
Olympic Swimmer Ryan Murphy Opens Up About Living with Eczema
Healthline· 5 days agoOlympic Swimmer Ryan Murphy and professional surfer Coco Ho are speaking out about living with...
UVA Health: Antibody used to treat asthma, eczema reduces risk of death from COVID-19
Augusta Free Press· 5 days agoA clinical trial conducted by UVA Health suggests that a monoclonal antibody used to treat asthma...
Letter: Trust your doctor, not Big Pharma's ads
Yakima Herald-Republic· 1 day agoTo the editor — Xiaflex, Eliquis, Prolia, Linzess, Austedo, Ozempic, Tepezza, Rybelsus, Trulicity, Otezla, Dupixent, Brezeti and the list goes on, as...
Surfer Coco Ho Talks About Competing In Her 30s
Forbes· 6 days agoBorn into a surfing family and set for life on the beach, pro surfer Coco Ho, now 31, has made Hawaii’s favorite pastime her full focus since her teens....
Benzinga Before The Bell: More Amazon Workers Join Union Over Pay and Work Conditions, UK Inflation...
Benzinga· 7 hours agoA BlackRock, Inc BLK Real Assets fund looks to acquire Akaysha Energy, an Australian firm that develops battery storage and renewable energy projects. BlackRock aims to commit over A$1 billion ...